Brief: Theratechnologies Inc Says 2023 Q3 Positive Adjusted EBITDA To Be Achieved
Sept 5 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES INC - 2023 Q3 POSITIVE ADJUSTED EBITDA
TO BE
ACHIEVED
* THERATECHNOLOGIES INC - AS AT AUGUST 31, 2023, ESTIMATES
THAT
ITS CASH, BONDS AND MONEY MARKET FUNDS, STOOD AT US$22.9 MILLION
Source text for Eikon: ID:nGNXbXKj8B
Further company coverage: TH.TO
((Reuters.briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process